Home » Nycomed/Merck: Daxas Deal Will Have Limited Financial Impact
Nycomed/Merck: Daxas Deal Will Have Limited Financial Impact
Nycomed and Merck & Co. have agreed to co-promote the novel therapy Daxas, which recently gained a positive recommendation in the EU.
TradingMarkets
TradingMarkets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May